Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study
-
Published:2024-05-10
Issue:
Volume:
Page:
-
ISSN:0022-3050
-
Container-title:Journal of Neurology, Neurosurgery & Psychiatry
-
language:
-
Short-container-title:
您需要登录后可以查看相关数据！